Immunotherapy for Parkinson’s disease

With the increasing prevalence of Parkinson’s disease (PD), there is an immediate need to interdict disease signs and symptoms. In recent years this need was met through therapeutic approaches focused on regenerative stem cell replacement and alpha-synuclein clearance. However, neither have shown lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Aaron D., Thurston, Mackenzie J., Machhi, Jatin, Olson, Katherine E., Namminga, Krista L., Gendelman, Howard E., Mosley, R. Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933730/
https://www.ncbi.nlm.nih.gov/pubmed/31978602
http://dx.doi.org/10.1016/j.nbd.2020.104760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933730/
https://www.ncbi.nlm.nih.gov/pubmed/31978602
http://dx.doi.org/10.1016/j.nbd.2020.104760

Ejemplares similares